Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms

SARS-CoV-2 infection can associate diverse neurological manifestations. Several studies have provided proof to support the theory of neurotropic involvement of SARS-CoV-2. Alpha-synuclein has been described as a native antiviral factor within neurons, and upregulation of this protein can be seen in...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco-Palmero, V. A., Azcárate-Díaz, F. J., Ruiz-Ortiz, M., Laespada-García, M. I., Rábano-Suárez, P., Méndez-Guerrero, A., Aramendi-Ramos, M., Eguiburu, J. L., Pérez-Rivilla, A., Marchán-López, A., Rubio-Fernández, M., Carro, E., González de la Aleja, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892700/
https://www.ncbi.nlm.nih.gov/pubmed/33606070
http://dx.doi.org/10.1007/s00415-021-10444-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892700/
https://www.ncbi.nlm.nih.gov/pubmed/33606070
http://dx.doi.org/10.1007/s00415-021-10444-6

Ejemplares similares